Malaria still kills thousands of children in Africa each year — but a vaccine might change all that.
Improvise, adapt, eliminate.
This is far from being a final drug, but it’s still extremely exciting.
Dogs really have an amazing sense of smell.
Strap your seatbelts, it’s creepy time.
Guess what: one more reason to hate mosquitoes.
Sneaky, sneaky plasmodium.
A drug developed in the 1980s to fight parasites can make human blood toxic to mosquitoes when taken in a high dose.
Not one day too soon!
This looks like a better alternative to wiping out mosquitoes at the population level.
Hundreds of thousands of infants will be vaccinated against the mosquito-carried parasite.
A mosquito with a gene that blocks the malaria parasite has been created in the laboratory, a new research reports.
A lifelong dream may have come true. Half a million deaths every year could be averted thanks to this vaccine.
Believe it or not, there’s actual scientific proof backing this advice.
Chemists at the Ohio State University developed a paper strip technology that might save countless lives in rural Africa, and elsewhere where patients have poor access to medical services.
Scientists have in the past toyed with the idea of using a disease to fight cancer. Now, after identifying a malaria protein that binds to cancer cells and kills 95% of tumor types, human trials are expected to start within four years. I doesn’t seem like it’s happening fast, but it is, in medical terms. Clinical trials take a lot of
Researchers stumbled upon a new tool to fight cancer in a rather unexpected place; while searching for a vaccine against malaria in pregnant women, a team of Danish scientists found that, simply put, armed malaria proteins are remarkably good at killing cancer cells. They hope to have a working prototype ready for human trials within four years’ time. Their discovery has been published in the scientific journal Cancer Cell.
This year’s Nobel Prize in Physiology or Medicine is split into three parts, being divided between William C. Campbell and Satoshi Ōmura — who jointly share a half “for their discoveries concerning a novel therapy against infections caused by roundworm parasites” — and Youyou Tu “for her discoveries concerning a novel therapy against Malaria.”
The ability to keep malaria under control is crucial – the disease is highly contagious and the potential health hazards are immense. Efforts have been somewhat successful, with fatalities dropping from over 1 million in 2000 to 584,000 in 2014. But the protozoans that are causing the disease are starting to become immune to the drugs we are using, and that’s a huge problem.
Malaria is one of the most common and dangerous diseases in the world, with the World Health Organization estimating over 200 million cases every year. There are several ways to try to treat malaria, but the results are debatable and often times not as effective as desired. Now, a team has demonstrated a new compound which effectively destroys malaria in